Addiante secures R$1bn funding to back deal with Ambipar
Summary
The deal was revealed to Valor by the Addiante CEO F\xe1bio Leite. The executive said Addiante received a R$300 million capital injection from shareholders and structured a R$750 million debenture issuance to back the investment.For this purpose [asset purchase and renewal], we secured R$300 million in investment (from shareholders Randoncorp and Gerdau) and raised R$750 million in the market through a debenture issuance, he said. The executive explained that the company has closed the fundraising with a group of investors and now awaits the approval of the Administrative Council for Economic Defense (CADE) before providing further details. We must wait for approval. After CADE approval, we have third-party investments in non-convertible debentures, the executive said, emphasizing that the issuance does not involve the entry of a new partner.
Funding
Review available funding amount, funding date, investors, and linked company information related to Addiante secures R$1bn funding to back deal with Ambipar in the interactive ISVWorld profile.